News about Clinical Trials

ProofPilot Announces Closing of its Series C Funding

ProofPilot has announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (USA), Inc. participating.

Clinical Trials | 12/07/2024 | By Aishwarya |  532

Merck Announces Update on Xevinapant Program in Locally Advanced Head and Neck Cancer

Merck has discontinued the Phase III randomized TrilynX study evaluating xevinapant plus chemoradiotherapy (CRT) in patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Clinical Trials | 27/06/2024 | By Aishwarya |  355

Medidata Rolls Out Clinical Data Studio to Deliver Safer Trials to Patients

Medidata has unveiled Medidata Clinical Data Studio, a unified experience that unlocks the true power of clinical research data.

Clinical Trials | 20/06/2024 | By Aishwarya |  679

Labcorp Rolls Out Global Trial Connect to Accelerate Clinical Trials

Labcorp has launched Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at increasing the speed of clinical trials where the heart of clinical research is conducted – investigator sites.

Clinical Trials | 18/06/2024 | By Aishwarya |  594

ConcertAI, NVIDIA to Transform Translational and Clinical Development Solutions

ConcertAI has joined hands with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform.

Clinical Trials | 03/06/2024 | By Aishwarya |  587

Johnson and Johnson to Obtain Rights to Clinical-Stage Bispecific Antibody

Johnson & Johnson has signed a definitive deal with Numab Therapeutics, to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to a novel, investigational first-in-class bispecific antibody, NM26.

Clinical Trials | 30/05/2024 | By Aishwarya |  295

NS Pharma Reports Preliminary Results of Viltolarsen Phase 3 Clinical Trial

NS Pharma, Inc. has received preliminary analysis results from the global Phase 3 clinical trial (RACER53 study, NCT04060199) of NS-065/NCNP-01.

Clinical Trials | 28/05/2024 | By Aishwarya |  443

Phastar and Beaconcure to Deliver Process Revolution in Clinical Data Review

Beaconcure Inc. has inked a strategic partnership with Phastar Inc. to enhance clinical review processes in clinical trials.

Clinical Trials | 21/05/2024 | By Aishwarya |  295

MetP Pharma Announces Preclinical Research Results of semaglutide Development

MetP Pharma has announced its preclinical research results that strongly support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.

Clinical Trials | 09/05/2024 | By Aishwarya |  590

Acumen Announces First Patient Dosed in ALTITUDE-AD

Acumen Pharmaceuticals, Inc. has announced that the first patient has been dosed with sabirnetug (ACU193) in the ALTITUDE-AD Phase 2 clinical trial designed to evaluate the clinical efficacy and safety of sabirnetug in patients with early AD.

Clinical Trials | 08/05/2024 | By Aishwarya |  437